Stroke Trial, Recruiting NCT04752319 Sponsor: The University of Texas Health Science Center, Houston Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT04752319
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who had a stroke at least 6 months ago and whose health is currently stable
  • People who had a single stroke on one side of the brain only (either a bleeding stroke or a blocked blood vessel stroke, of any size)
  • People who have some detectable stiffness or tightness in the finger-bending muscles (as measured by a standard clinical scale called the MAS, with a score of 1 or higher)

Who may not be able to join:

  • People who have problems with vision, difficulty noticing things on one side, hearing problems, or cognitive (thinking/memory) difficulties
  • People who have a history of lung conditions such as asthma or chronic obstructive pulmonary disease (COPD)
  • People who are currently in the process of changing medications that affect muscle tone (for example, a medication called baclofen)
  • People who have had botulinum toxin (such as Botox) injected into the arm or fingers within the last 4 months, or phenol injections within the last 2 years
  • People who have a pacemaker (a device implanted to help regulate the heart)
  • People who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sheng Li, MD, PhD, University of Texas

Phone: (713) 797-7125

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in finger flexor spasticity measured by Modified Ashworth Scale (MAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov